Authors:
Kereiakes, DJ
Fry, E
Matthai, W
Niederman, A
Barr, L
Brodie, B
Zidar, J
Casale, P
Christy, G
Moliterno, D
Lengerich, R
Broderick, T
Shimshak, T
Cohen, M
Citation: Dj. Kereiakes et al., Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first", J INVAS CAR, 12, 2000, pp. 1A-5A
Authors:
Kereiakes, DJ
McDonald, M
Broderick, T
Roth, EM
Whang, DD
Martin, LH
Howard, WL
Schneider, J
Shimshak, T
Abbottsmith, CW
Citation: Dj. Kereiakes et al., Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use modelfor expediting care in acute coronary syndromes, AM HEART J, 139(2), 2000, pp. S53-S60
Authors:
Kereiakes, DJ
Broderick, TM
Roth, EM
Whang, D
Shimshak, T
Runyon, JP
Hattemer, C
Schneider, J
Lacock, P
Mueller, M
Abbottsmith, CW
Citation: Dj. Kereiakes et al., Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention, AM J CARD, 84(4), 1999, pp. 391-395